Search Results - daniel+schultz

2 Results Sort By:
Small-Molecule IL-6 Inhibitors Targeting gp130 for Anti-Cancer Therapy
Blocks IL-6-gp130 Signaling for Cost-Effective Treatment of Autoimmune Diseases and IL-6–Driven Cancers These small-molecule interleukin-6 (IL-6) inhibitors target glycoprotein 130 (gp130) by blocking IL-6-gp130 signaling, delivering a cost-effective therapy for autoimmune diseases and IL-6-driven cancers. IL-6-gp130 signaling drives tumor growth...
Published: 3/2/2026   |   Inventor(s): Chenglong Li, Liguang Mao, Daniel Schultz, Zhihang Shen, Xiaozhi Yang, Wei Zhou
Keywords(s):  
Category(s): Technology Classifications > Human Health Care > Therapeutics
Rapid and High Yield Reduction of CO2 to Commercially Valuable Multi Carbon Products
Rapid and High Yield Reduction of CO2 to Commercially Valuable Multi Carbon Products Princeton Docket # 18-3372-1 The laboratory of Prof. Andrew Bocarsly has created a collection of alloy electrodes capable of reducing CO2 to high value multi-carbon products in a fast, efficient, and high yield manner that is industrially attractive for CO2...
Published: 2/4/2025   |   Inventor(s): Aubrey Paris, Sonja Francis, An Chu, Andrew Bocarsly
Keywords(s):  
Category(s): Chemistry